InSight Biopharmaceutical

Developers and manufacturers of biosimilars and sophisticated generics for the treatment of major diseases and disorders.

Health Tech & Life Sciences
Acquired by Gencor Pacific
Acquired Rehovot, Israel Founded 1995
Last updated 2026-07-19
Total raised
Stage
Acquired
Founded
1995
Headcount
16
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

InSight Biopharmaceutical develops biosimilar drugs with properties virtually identical to other previously approved drugs. The company has focused on introducing biosimilars to major markets through strategic alliances. Insight Biopharmaceutical's portfolio consists of a wide range of biosimilars in the fields of fertility, oncology, neurology, and rheumatology. In 2017, the company's intellectual property and assets were sold to Estonian company PharmaEstica Manufacturing and its Israeli partner. InSight is conducting the acquisition through InSight Innovation Ltd, a subsidiary it established specifically for the deal.

Headcount over time

From 48 (2017-07) to 15 (2024-10) · -33 (-69%) · 16 points · source: Finder history + radar grounding
480 2017-07 2024-10

Q&A

What is the current status of InSight Biopharmaceutical?
InSight Biopharmaceutical was acquired by Gencor Pacific in January 2019 and is currently inactive.
When was InSight Biopharmaceutical founded?
InSight Biopharmaceutical was founded in June 1995.
What is InSight Biopharmaceutical's primary business?
InSight Biopharmaceutical develops biosimilar drugs with properties virtually identical to other previously approved drugs, focusing on fertility, oncology, neurology, and rheumatology.
Who acquired InSight Biopharmaceutical and for what amount?
InSight Biopharmaceutical was acquired by Gencor Pacific in January 2019 for $2,500,000.
Where is InSight Biopharmaceutical headquartered?
InSight Biopharmaceutical is headquartered in Rehovot, Center District, Israel.
How many employees does InSight Biopharmaceutical have?
InSight Biopharmaceutical has 11-50 employees.
Who is the Co-founder and CEO of InSight Biopharmaceutical?
Naim Tamari is the Co-founder and CEO of InSight Biopharmaceutical.
Does InSight Biopharmaceutical hold any patents?
Yes, InSight Biopharmaceutical holds one patent.

Team · 1

Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

oncologyfertilityneurology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteinsight.co.il
LinkedInlinkedin.com/company/1227626

Identifiers & details

Legal nameINSIGHT BIOPHARMACEUTICALS LTD
Founded1995-6
Employees (exact)16
Status reasonAcquired (Inactive) by PharmaEstica Manufacturing on Jul 2017 - closed due to acquisition

Acquisitions & public offerings

Acquired by Gencor Pacific 2019-01 $2.5M

Radar intelligence

Patents

EPO2

Web history (Wayback)

Domaininsight.co.il

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515812501
Statusמחוסלת מרצון — CLOSED
Corp typeישראלית חברה פרטית
Incorporated2018-03-08
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2022
Active charges / liens0
Registry events0
Registered addressהמדע 12 רחובות